NCT04484623 - Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma | Biotech Hunter

Enrollment

302

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

January 29, 2024

Study Completion Date

October 25, 2029

Conditions

Multiple Myeloma

Interventions

DRUG

Belantamab mafodotin

Humanized anti-B-cell maturation antigen (BCMA) antibody/drug conjugate will be administered.

DRUG

Pomalidomide

Immunomodulatory drug (IMiD) will be administered.

DRUG

Dexamethasone

Synthetic glucocorticoid with anti-tumor activity will be administered.

DRUG

Bortezomib

Proteasome Inhibitor will be administered.

Trial Locations (119)

622

GSK Investigational Site, Takapuna Auckland

1023

GSK Investigational Site, Grafton

2010

GSK Investigational Site, Darlinghurst

2025

GSK Investigational Site, Auckland

2250

GSK Investigational Site, Gosford NSW

2444

GSK Investigational Site, Port Macquarie

2605

GSK Investigational Site, Garran

3065

GSK Investigational Site, Fitzroy

3084

GSK Investigational Site, Heidelberg

3143

GSK Investigational Site, Tauranga

3144

GSK Investigational Site, Malvern

3204

GSK Investigational Site, Hamilton

4101

GSK Investigational Site, South Brisbane

4217

GSK Investigational Site, Benowa

5000

GSK Investigational Site, Adelaide

6009

GSK Investigational Site, Nedlands

6340

GSK Investigational Site, Ankara

6560

GSK Investigational Site, Ankara

8035

GSK Investigational Site, Barcelona

9016

GSK Investigational Site, Dunedin

10408

GSK Investigational Site, Gyeonggi-do

10676

GSK Investigational Site, Athens

12808

GSK Investigational Site, Prague

13273

GSK Investigational Site, Marseille

20122

GSK Investigational Site, Milan

21565

GSK Investigational Site, Inchon

27100

GSK Investigational Site, Pavia

28006

GSK Investigational Site, Madrid

28027

GSK Investigational Site, Madrid

28223

GSK Investigational Site, Pozuelo de AlarcOn Madr

28933

GSK Investigational Site, MOstoles Madrid

30008

GSK Investigational Site, Murcia

31008

GSK Investigational Site, PamplonaNavarra

31059

GSK Investigational Site, Toulouse

33204

GSK Investigational Site, Gijón

33343

GSK Investigational Site, Mersin

33901

GSK Investigational Site, Fort Myers

35100

GSK Investigational Site, Izmir

35330

GSK Investigational Site, Izmir

37007

GSK Investigational Site, Salamanca

37203

GSK Investigational Site, Nashville

40138

GSK Investigational Site, Bologna

41013

GSK Investigational Site, Seville

41400

GSK Investigational Site, Kocaeli

46026

GSK Investigational Site, Valencia

50333

GSK Investigational Site, Hradec Králové

54511

GSK Investigational Site, Vanduvre-lEs-Nancy

55131

GSK Investigational Site, Mainz

55139

GSK Investigational Site, Samsun

57010

GSK Investigational Site, Thessaloniki

58128

GSK Investigational Site, Hwasun

62500

GSK Investigational Site, Brno

64132

GSK Investigational Site, Kansas City

72076

GSK Investigational Site, Tübingen

85712

GSK Investigational Site, Tucson

91031

GSK Investigational Site, Jerusalem

97080

GSK Investigational Site, Würzburg

100191

GSK Investigational Site, Beijing

110004

GSK Investigational Site, Shenyang

125101

GSK Investigational Site, Moscow

125284

GSK Investigational Site, Moscow

130012

GSK Investigational Site, Changchun

191024

GSK Investigational Site, Saint Petersburg

194291

GSK Investigational Site, Saint Petersburg

197341

GSK Investigational Site, Saint Petersburg

221004

GSK Investigational Site, Jiangsu

300020

GSK Investigational Site, Tianjin

310003

GSK Investigational Site, Hangzhou

330006

GSK Investigational Site, Nanchang

354057

GSK Investigational Site, Sochi

410013

GSK Investigational Site, Changsha

443099

GSK Investigational Site, Samara

630087

GSK Investigational Site, Novosibirsk

2633737

GSK Investigational Site, Nahariya

3109601

GSK Investigational Site, Haifa

4428164

GSK Investigational Site, Kfar Saba

4941492

GSK Investigational Site, Petah Tikva

6423906

GSK Investigational Site, Tel Aviv

02215

GSK Investigational Site, Boston

01308-050

GSK Investigational Site, Curitiba

89201-260

GSK Investigational Site, Joinville

90035-903

GSK Investigational Site, Porto Alegre

04537-081

GSK Investigational Site, São Paulo

Unknown

GSK Investigational Site, Beijing

115 25

GSK Investigational Site, Athens

115 28

GSK Investigational Site, Athens

45 500

GSK Investigational Site, Ioannina

00161

GSK Investigational Site, Roma

467-8602

GSK Investigational Site, Aichi

277-8567

GSK Investigational Site, Chiba

296-8602

GSK Investigational Site, Chiba

790-8524

GSK Investigational Site, Ehime

960-1295

GSK Investigational Site, Fukushima

371-8511

GSK Investigational Site, Gunma

377-0280

GSK Investigational Site, Gunma

060-8648

GSK Investigational Site, Hokkaido

028-3695

GSK Investigational Site, Numakunai

701-1192

GSK Investigational Site, Okayama

565-0871

GSK Investigational Site, Osaka

683-8504

GSK Investigational Site, Tottori

990-9585

GSK Investigational Site, Yamagata

85-168

GSK Investigational Site, Bydgoszcz

80-214

GSK Investigational Site, Gdansk

31-501

GSK Investigational Site, Krakow

93-513

GSK Investigational Site, Lodz

50-367

GSK Investigational Site, Wroclaw

03080

GSK Investigational Site, Seoul

03722

GSK Investigational Site, Seoul

06351

GSK Investigational Site, Seoul

06591

GSK Investigational Site, Seoul

08036

GSK Investigational Site, Barcelona

08908

GSK Investigational Site, L'Hospitalet de Llobrega

07120

GSK Investigational Site, Palma de Mallorca

06100

GSK Investigational Site, Ankara

W12 0HS

GSK Investigational Site, London

PL6 8D8

GSK Investigational Site, Plymouth

SO16 6YD

GSK Investigational Site, Southampton

ST4 6QG

GSK Investigational Site, Stoke-on-Trent

SM2 5PT

GSK Investigational Site, Sutton